Dr. Armstrong Honored for Service as an ABFPRS Oral Examiner
Supporting rigorous standards in facial plastic and reconstructive surgery Michael Armstrong Jr., M.D., recently returned from Arlington, Virginia, where he served a...
Richmond ENT Helps Advance a Promising New Treatment for Chronic Sinusitis
Dr. Michael Armstrong served as a principal investigator in the successful Phase 3 ENLIGHTEN 2 clinical study. Richmond ENT is proud to have participated in ENLIGHTE...
Biologics for Chronic Sinusitis with Nasal Polyps: A Proud Moment and an Update for Patients
I am delighted to congratulate my son, Michael F. Armstrong, MD, on his recent publication, “Biologics in Chronic Rhinosinusitis with Nasal Polyps: The Otolaryngologi...
Climate Change is Worsening your Allergies and Sinus Problems
A recent article in the Journal of the American Medical Association highlights something many patients already feel: allergy seasons seem longer, symptoms seem strong...
Still Stuffy? What TEZSPIRE® Means for Chronic Sinusitis with Nasal Polyps
Ask the Surgeon: What’s New in Nasal Polyps? By Rob Thomas, MD (Richmond ENT) If you’ve struggled with nasal polyps, you already know how disruptive they can be—blo...
Richmond ENT Attends SEAAIS Annual Meeting at The Greenbrier
Dr. Michael Armstrong, MD, along with nurse practitioners Becky Andrews, FNP, and Amy Meadors, FNP, recently attended the 2025 Annual Meeting of the Southeastern Alle...
Richmond ENT demonstrates an effective new treatment for Chronic Rhinitis
Richmond ENT is proud to announce its role as a clinical study center in a major national research trial evaluating a new, minimally invasive treatment for chronic rh...
Why FACEforward® and ABFPRS Certification Matter When Choosing a Facial Plastic Surgeon
FACEforward® 2025: A Commitment to Lifelong Learning We are proud to share that Dr. Michael Armstrong recently completed the annual FACEforward® longitudinal assessm...
New Genetic Test Helps Personalize Skin Cancer Care at Richmond ENT
At Richmond ENT, we are committed to bringing our patients the most advanced tools available for the diagnosis and treatment of skin cancer. One of these tools is the...
Richmond ENT Celebrates Cigna Coverage of Neuromark® for Chronic Rhinitis
RICHMOND, VA – September 15, 2025 – Richmond ENT is proud to share that Cigna Healthcare has announced expanded coverage for posterior nasal nerve ablation treatments...